BCRX
BioCryst Pharmaceuticals, Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables):
amplitud de titulares +10.0% ·
flujo de acciones -1.3% ·
nuevas posiciones netas +4.5%
· fórmula
Fragmentación de la titularidad: más titulares, participación agregada más pequeña
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 107 | +3 | 139.01M | $1.39B | +7 | −5 |
| Q1 2026 | 108 | +4 | 130.67M | $1.24B | +14 | −10 |
| Q4 2025 | 103 | -1 | 127.11M | $991.41M | n/a | −1 |
| Q3 2025 | 22 | +2 | 89.66M | $680.51M | +2 | −1 |
| Q2 2025 | 18 | +1 | 80.75M | $723.56M | +1 | n/a |
| Q1 2025 | 14 | +1 | 26.41M | $198.06M | +1 | n/a |
| Q4 2024 | 13 | -2 | 21.17M | $159.22M | n/a | −2 |
| Q3 2024 | 14 | +4 | 16.62M | $126.32M | +4 | n/a |
| Q2 2024 | 10 | n/a | 15.77M | $97.44M | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (pasivo) | 21.79M | +6.1% | $165.39M | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 2 | BlackRock ✦ (pasivo) | 21.25M | -0.8% | $161.26M | 0.0% | ▼ Trim | 2 | SEC ↗ ×16 |
| 3 | State Street Global Advisors ✦ (pasivo) | 9.81M | +15.3% | $74.44M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Arrowstreet Capital ✦ | 5.23M | +22.1% | $39.67M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 5 | Morgan Stanley ✦ | 5.20M | n/a | $39.49M | 0.0% | n/c | 1 | SEC ↗ ×9 |
| 6 | Geode Capital Management ✦ (pasivo) | 5.05M | -0.1% | $38.35M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 7 | Two Sigma Investments ✦ | 4.42M | +3.1% | $33.54M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 8 | Goldman Sachs Group ✦ | 2.71M | n/a | $20.58M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 9 | Fisher Asset Management ✦ | 2.63M | -5.4% | $19.98M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 10 | JPMorgan Chase ✦ | 2.26M | n/a | $17.19M | 0.0% | n/c | 1 | SEC ↗ ×12 |
| 11 | Renaissance Technologies ✦ | 2.14M | -15.3% | $16.25M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 12 | D. E. Shaw & Co. ✦ | 1.71M | -61.1% | $12.97M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 13 | Citadel Advisors ✦ | 1.36M | -46.8% | $10.32M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 14 | AQR Capital Management ✦ | 999.78K | -13.0% | $7.59M | 0.0% | ▼ Trim | 6 | SEC ↗ ×5 |
| 15 | Marshall Wace ✦ | 731.41K | +410.4% | $5.55M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 16 | Fidelity (FMR) ✦ | 653.81K | -0.3% | $4.96M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 17 | Millennium Management ✦ | 460.95K | -75.8% | $3.50M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 18 | Bridgewater Associates ✦ | 411.50K | Nuevo | $3.12M | 0.0% | New | 1 | SEC ↗ |
| 19 | Gotham Asset Management ✦ | 343.77K | +70.3% | $2.61M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 20 | Point72 Asset Management ✦ | 238.19K | Nuevo | $1.81M | 0.0% | New | 1 | SEC ↗ |
| 21 | T. Rowe Price ✦ | 161.35K | +10.0% | $1.23M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 22 | Wellington Management ✦ | 93.53K | +7.8% | $709,893 | 0.0% | ▲ Add | 5 | SEC ↗ ×4 |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Bridgewater Associates | $3.12M | 0.0% |
| Point72 Asset Management | $1.81M | 0.0% |
Posición cerrada
| Norges Bank | $995,922 | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 298 tenedores, 245.96M acciones, $2.30B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.